Abstract
There are scanty data on the prevalence of vitamin D deficiency and its relation to disease activity among patients with juvenile-onset systemic lupus erythematosus (JoSLE) in the Middle East and North Africa, an area known to be endemic for vitamin D deficiency and insufficiency. The aim of this study was, therefore, to study vitamin D status and its relation to disease activity and parameters in Egyptian patients with JoSLE. Serum levels of 25(OH) D3 in 70 JoSLE patients were compared to 40 age-, sex-, and body mass index-matched healthy controls. The 25(OH) D3 was determined by enzyme-linked immunosorbent assay. Information regarding the medical history, clinical symptoms, and signs was registered at the time of serum sampling. Disease activity of SLE was evaluated according to the SLEDAI score. The mean level of serum 25(OH) D3 was 12 ± 3.7 in JoSLE patients compared to 21 ± 3.5 ng/mL in normal controls (p < 0.001). Forty percent (28/70) of the JoSLE patients has severe 25(OH) D3 deficiency (≤10 ng/mL), and 60 % of the JoSLE patients has 25(OH) D3 insufficiency (≤30 ng/mL). None of the JoSLE patients has 25(OH) D3 level >30 ng/mL. There was no significant correlation between serum levels of 25(OH) D3 and the demographic data, medication used, and some laboratory data of patients with JoSLE. Disease activity score in our patients was insignificantly correlated with serum levels of 25(OH) D3. In spite of vitamin D supplementation in Egyptian JoSLE patients and the presence of vitamin D insufficiency in the control group, there are still significantly lower levels of vitamin D in JoSLE compared to normal controls.
Similar content being viewed by others
References
Mahon BD, Wittke A, Weaver V, Cantorna MT (2003) The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922–932
Veldman CM, Cantorna MT, DeLuca HF (2000) Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374:334–338
Bhalla AK, Amento EP, Serog B, Glimcher LH (1984) 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 133:1748–1754
Mattner F, Smiroldo S, Galbiati F et al (2000) Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur J Immunol 30:498–508
Lemire JM, Archer DC, Beck L, Spiegelberg HL (1995) Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 125(Suppl 6):1704S–1708S
Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A (2001) 1Alpha,25-dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167:4974–4980
Overbergh L, Decallonne B, Waer M, Rutgeerts O, Valckx D (2000) 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 49:1301–1307
Lemire JM, Adams JS, Sakai R, Jordan SC (1984) 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Investig 74:657–661
Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R (2001) Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 98:6800–6805
Penna G, Adorini L (2000) 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 64:2405–2411
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281
Woodhouse NYJ, Norton WL (1982) Low vitamin D level in Saudi Arabians. King Faisal Spec Hosp Med J 2:127–131
Sedrani SH, Elidrissy AW, El Arabi KM (1983) Sunlight and vitamin D status in normal Saudi subjects. Am J Clin Nutr 38(1):129–132
Pietras SM, Obayan BK, Cai MH, Holick MF (2009) Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Arch Intern Med 169(19):1806–1808
Sadat-Ali M, AlElq A, Al-Turki H, Al-Mulhim F, Al-Ali A (2009) Vitamin D levels in healthy men in eastern Saudi Arabia. Ann Saudi Med 29(5):378–382
Elsammak MY, Al-Wossaibi AA, Al-Howeish A, Alsaeed J (2011) High prevalence of vitamin D deficiency in the sunny Eastern region of Saudi Arabia: a hospital-based study. East Mediterr Health J 17(4):317–322
Ministry of Health, Oman. Muscat: Ministry of Health (2008) Micronutrients testing, community health and disease surveillance newsletter, pp 12–13
Al-Kindi MK (2011) Vitamin D status in healthy Omani women of childbearing age: study of female staff at the Royal Hospital, Muscat, Oman. Sultan Qaboos Univ Med J 11(1):56–61
Al Kalbani M, Elshafie O, Rawahi M, Al-Mamari A, Al-Zakwani A, Woodhouse N (2011) Vitamin D Status in Pregnant Omanis: a disturbingly high proportion of patients with low vitamin D stores. Sultan Qaboos Univ Med J 11(1):52–55
Saadi HF, Dawodu A, Afandi BO, Zayed R, Benedict S, Nagelkerke N (2007) Efficacy of daily and monthly high-dose calciferol in vitamin D-deficient nulliparous and lactating women. Am J Clin Nutr 85(6):1565–1571
Dawodu A, Kochiyil J, Altaye N (2011) Pilot study of sunlight exposure and vitamin D status in Arab women of childbearing age. East Mediterr Health J 17(7):570–574
Al Anouti F, Thomas J, Abdel-Wareth L, Rajah J, Grant WB, Haq A (2011) Vitamin D deficiency and sun avoidance among university students at Abu Dhabi, United Arab Emirates. Dermatoendocrinol 3(4):235–239
Bener A, Al-Ali M, Hoffmann GF (2009) High prevalence of vitamin D deficiency in young children in a highly sunny humid country: a global health problem. Minerva Pediatr 61(1):15–22
Mahdy S, Al-Emadi SA, Khanjar IA, Hammoudeh MM, Sarakbi HA, Siam AM, Abdelrahman MO (2010) Vitamin D status in health care professionals in Qatar. Saudi Med J 31(1):74–77
Prentice A, Schoenmakers I, Jones KS, Jarjou LMA, Goldberg GR (2009) Vitamin D deficiency and its health consequences in Africa. Clinic Rev Bone Miner Metab 7:94–106
Amr N, Hamid A, Sheta M, Elsedfy H (2012) Vitamin D status in healthy Egyptian adolescent girls. Georgian Med News 210:65–71
Alagöl F, Shihadeh Y, Boztepe H, Tanakol R, Yarman S, Azizlerli H et al (2000) Sunlight exposure and vitamin D deficiency in Turkish women. J Endocrinol Investig 23(3):173–177
Mishal AA (2001) Effects of different dress styles on vitamin D levels in healthy young Jordanian women. Arch Osteoporos 12:931–935
O’Regan S, Chesney RW, Hamstra A, Eisman JA, O’ Gorman AM, Deluca HF (1979) Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone- treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand 68:109–111
Chaiamnuay S, Chailurkit L, Narongroeknawin P, Asavatanabodee P, Laohajaroensombat S, Chaiamnuay P (2013) Current daily glucocorticoid use and serum creatinine levels are associated with lower 25(OH) vitamin D levels in Thai patients with systemic lupus erythematosus. JCR 19(3):121–125
Huisman AM, White KP, Algra A, Harth M, Vieth R, Jacobs JW et al (2001) Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 28:2535–2539
Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 52:2044–2050
Muller K, Kriegbaum NJ, Baslund B, Sørensen OH, Thymann M, Bentzen K (1995) Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 14:397–400
Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS (2006) Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5:114–117
Cutolo M, Otsa K (2008) Review: vitamin D, immunity and lupus. Lupus 17:6–10
Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE (2007) Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179:1634–1647
Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G et al (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann NY Acad Sci 1109:385–400
Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C (2008) Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 2047:920–923
Abou-Raya A, Abou-Raya S, Helmii M (2013) The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol 40:265–272
Emerah A, El-Shal A (2013) Role of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D level in Egyptian female patients with systemic lupus erythematosus. Mol Biol Rep 40:6151–6162
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI.A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630–640
Wielders JP, Wijnberg FA (2009) Preanalytical stability of 25(OH)—vitamin D3 in human blood or serum at room temperature: solid as a rock. Clin Chem 55(8):1584–1585
Alshishtawy MM (2012) Vitamin D Deficiency: this clandestine endemic disease is veiled no more. Sultan Qaboos Univ Med J 12(2):140–152
Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362–371
Cantorna MT, Mahon BD (2004) Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 229:1136–1142
Casella CB, Seguro LP, Takayama L, Medeiros D, Bonfa E, Pereira RM (2012) Juvenile onset systemic lupus erythematosus: a possible role for vitamin D in disease status and bone health. Lupus 21(12):1335–1342
Conflict of interest
All authors have no conflict of interest in relation to the research topic, and the authors did not receive any funding concerning this research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Garf, K.E., Marzouk, H., Farag, Y. et al. Vitamin D status in Egyptian patients with juvenile-onset systemic lupus erythematosus. Rheumatol Int 35, 1535–1540 (2015). https://doi.org/10.1007/s00296-015-3245-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-015-3245-x